FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206781330> ?p ?o ?g. }

• W4206781330 abstract "Introduction. Medullary thyroid cancer (MTC) belongs to a class of rare neuroendocrine aggressive tumors and arises from parafollicular cells (C-cells). An important modern problem is the development of ways to predict the recurrence of this disease. The aim of the study is to determine the role of immunohistochemical tumor markers of medullary thyroid cancer in predicting recurrence or death. Materials and methods. The analysis of the prospective study included 22 patients with MTC, 5 of whom have developed a recurrence and 4 have died at the end of the 10-year (120 months) follow-up period. Immunohistochemical examinations were performed using monoclonal antibodies of tumor markers calcitonin, chromogranin A, vimentin and Ki-67. Results. The discrepancy between the data of histological and immunohistochemical examinations in MTC is 12.0%, which indicates the hyperdiagnosis of this nosology and argues the importance of performing immunohistochemical examinations to verify the diagnosis. Patients who had a recurrence of MTC had significantly (p <0.05) lower levels of calcitonin expression (5.00 [5.00; 5.00] points) compared with patients who did not relapse, where this figure was 6.00 [6.00; 7.00] points. In patients with MTC, an increase in calcitonin expression was significantly associated with an increase in chromogranin A expression (r = + 0.49, p = 0.02); a similar relationship was found for the proportions of immunopositive cells of these tumor markers: r = + 0.68, p = 0.001. At the same time, it was found that the increase in the level of calcitonin expression was apparently combined with the decrease in the level of Ki-67 expression (r = -0.52, p = 0.02). It was also found that the increase in the level of vimentin expression is combined with an increase in the expression (r = + 0.64, p = 0.001) and the proportion of immunopositive cells of chromogranin A (r = + 0.45, p = 0.038). Conclusions. Low levels of calcitonin expression are prognostically unfavorable markers for the recurrence of MTC. Specific tumor markers are important in the treatment process and for the dynamic monitoring of patients with MTC." @default.
• W4206781330 created "2022-01-25" @default.
• W4206781330 creator A5020418799 @default.
• W4206781330 creator A5041166545 @default.
• W4206781330 creator A5057269208 @default.
• W4206781330 creator A9999999999 @default.
• W4206781330 date "2021-12-29" @default.
• W4206781330 modified "2023-10-14" @default.
• W4206781330 title "THE ROLE OF IMMUNOHISTOCHEMICAL MARKERS IN PREDICTING RECURRENCE OR DEATH IN PATIENTS WITH MEDULAR THYROID CANCER" @default.
• W4206781330 doi "https://doi.org/10.25040/ntsh2021.02.19" @default.
• W4206781330 hasPublicationYear "2021" @default.
• W4206781330 type Work @default.
• W4206781330 citedByCount "0" @default.
• W4206781330 crossrefType "journal-article" @default.
• W4206781330 hasAuthorship W4206781330A5020418799 @default.
• W4206781330 hasAuthorship W4206781330A5041166545 @default.
• W4206781330 hasAuthorship W4206781330A5057269208 @default.
• W4206781330 hasAuthorship W4206781330A9999999999 @default.
• W4206781330 hasBestOaLocation W42067813301 @default.
• W4206781330 hasConcept C121608353 @default.
• W4206781330 hasConcept C126322002 @default.
• W4206781330 hasConcept C142724271 @default.
• W4206781330 hasConcept C143998085 @default.
• W4206781330 hasConcept C147447768 @default.
• W4206781330 hasConcept C204232928 @default.
• W4206781330 hasConcept C2779627488 @default.
• W4206781330 hasConcept C2779761222 @default.
• W4206781330 hasConcept C2780120053 @default.
• W4206781330 hasConcept C526584372 @default.
• W4206781330 hasConcept C71924100 @default.
• W4206781330 hasConcept C77231918 @default.
• W4206781330 hasConceptScore W4206781330C121608353 @default.
• W4206781330 hasConceptScore W4206781330C126322002 @default.
• W4206781330 hasConceptScore W4206781330C142724271 @default.
• W4206781330 hasConceptScore W4206781330C143998085 @default.
• W4206781330 hasConceptScore W4206781330C147447768 @default.
• W4206781330 hasConceptScore W4206781330C204232928 @default.
• W4206781330 hasConceptScore W4206781330C2779627488 @default.
• W4206781330 hasConceptScore W4206781330C2779761222 @default.
• W4206781330 hasConceptScore W4206781330C2780120053 @default.
• W4206781330 hasConceptScore W4206781330C526584372 @default.
• W4206781330 hasConceptScore W4206781330C71924100 @default.
• W4206781330 hasConceptScore W4206781330C77231918 @default.
• W4206781330 hasIssue "2" @default.
• W4206781330 hasLocation W42067813301 @default.
• W4206781330 hasOpenAccess W4206781330 @default.
• W4206781330 hasPrimaryLocation W42067813301 @default.
• W4206781330 hasRelatedWork W1527087696 @default.
• W4206781330 hasRelatedWork W1571005155 @default.
• W4206781330 hasRelatedWork W1978591996 @default.
• W4206781330 hasRelatedWork W1987577069 @default.
• W4206781330 hasRelatedWork W2011919578 @default.
• W4206781330 hasRelatedWork W2014803876 @default.
• W4206781330 hasRelatedWork W2076353195 @default.
• W4206781330 hasRelatedWork W2163387375 @default.
• W4206781330 hasRelatedWork W2405409618 @default.
• W4206781330 hasRelatedWork W4206781330 @default.
• W4206781330 hasVolume "65" @default.
• W4206781330 isParatext "false" @default.
• W4206781330 isRetracted "false" @default.
• W4206781330 workType "article" @default.